Add like
Add dislike
Add to saved papers

Surgical management of refractory trochanteric bursitis.

We reviewed a single surgeon's experience with the surgical management of refractory trochanteric bursitis in an active population group. The surgical procedure consisted of simple longitudinal release of the iliotibial band over the greater trochanter and excision of the subgluteal bursa. To our knowledge, this is the first series to use this technique. Seven hips in five patients form the basis of the study, making it one of the largest surgical series reported. All patients had no improvement after a minimum of 1 year of nonoperative management consisting of nonsteroidal antiinflammatory medication, iliotibial band stretching, diathermy, ultrasound, and injections of local anesthetics combined with corticosteroids (average, 4.8 injections). Patients had experienced symptoms preoperatively for an average of 3.8 years and had noted marked limitation in vocational and recreational activities. The preoperative Harris hip score averaged 51.7. Four of the five patients (six hips) were available for evaluation at the time of this study, at an average of 20 months postoperatively. The average Harris hip score was 95.0. All patients were satisfied with the surgical results and had returned to unrestricted vocational and athletic activities. The remaining patient was last seen 6 months postoperatively and her Harris hip score had improved from 49 to 84.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app